| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,711 | 3,362 | 2,021 | 2,240 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 3,711 | 3,362 | 2,021 | 2,240 | | | Operating Expenses | | Research Development | 1,515 | 1,891 | 2,120 | 3,889 | | Selling General and Administrative | 1,352 | 1,036 | 1,361 | 957 | | Non Recurring | 115 | (6,873) | 334 | 8,283 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 729 | 7,308 | (1,794) | (10,889) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (58) | 2 | 10 | 40 | | Earnings Before Interest And Taxes | 671 | 7,310 | (1,784) | (10,849) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 671 | 7,310 | (1,784) | (10,849) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 671 | 7,310 | (1,784) | (10,849) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 671 | 7,310 | (1,784) | (10,849) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $671 | $7,310 | ($1,784) | ($10,849) |
|
0.02% Nasdaq 
0.33%
Income Statement
